CO19 Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Atezolizumab in combination with carboplatin-etoposide is indicated for the first-line treatment of extensive-stage small-cell lung cancer(ES-SCLC). The aim of our study is to analyze the effectiveness and safety of atezolizumab combined with chemotherapy in ES-SCLC in a tertiary hospital, and to compare with the pivotal IMpower133 trial.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research